This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Results 1-10 of 466 for CTIC in 0.017 secs

Why Cell Therapeutics (CTIC) Stock Is Spiking Today

By Tony Owusu 12:27 PM EDT 05/22/14

Cell Therapeutics (CTIC) is rocketing up today after being initiated with a 'buy' rating by analysts at Ladenburg (LTS).

http://www.thestreet.com/story/12719239/1/why-cell-therapeutics-ctic-stock-is-spiking-today.html

Heavy Early Morning Activity On Cell Therapeutics (CTIC)

By Jamie Hodge 09:14 AM EST 11/18/13

Trade-Ideas LLC identified Cell Therapeutics (CTIC) as a pre-market mover with heavy volume candidate

http://www.thestreet.com/story/12113212/1/heavy-early-morning-activity-on-cell-therapeutics-ctic.html

First Week of CTIC January 2016 Options Trading

By DividendChannel.com 01:18 PM EST 01/22/14

Investors in Cell Therapeutics, Inc. saw new options become available this week, for the January 2016 expiration.

http://www.thestreet.com/story/12257659/1/first-week-of-ctic-january-2016-options-trading.html

Interesting CTIC Put And Call Options For June 2014

By DividendChannel.com 10:53 AM EDT 10/23/13

Investors in Cell Therapeutics, Inc. saw new options begin trading this week, for the June 2014 expiration.

http://www.thestreet.com/story/12079568/1/interesting-ctic-put-and-call-options-for-june-2014.html

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs